Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,234
datasets available to search
ShareScore release 0.9.0
Dataset results
2,234 results for “Paclitaxel”
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Po
ClinicalTrials.gov study NCT03726879. IPD Sharing: YES. Countries: 12. Publications: 1.
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
ClinicalTrials.gov study NCT00010257. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00770809. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)
ClinicalTrials.gov study NCT05116189. IPD Sharing: YES. Countries: 25. Publications: 1.
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene
ClinicalTrials.gov study NCT01506609. IPD Sharing: YES. Countries: 20. Publications: 2.
Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00075270. IPD Sharing: Not stated. Countries: 25. Publications: 3.
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma
ClinicalTrials.gov study NCT01107665. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00096226. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers
ClinicalTrials.gov study NCT02392637. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03776812. IPD Sharing: NO. Countries: 5. Publications: 2.
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients
ClinicalTrials.gov study NCT01063517. IPD Sharing: YES. Countries: 1. Publications: 1.
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
ClinicalTrials.gov study NCT00655876. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine Cancer
ClinicalTrials.gov study NCT00584857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
ClinicalTrials.gov study NCT02769832. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT00844649. IPD Sharing: Not stated. Countries: 11. Publications: 16.
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00888615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
ClinicalTrials.gov study NCT01081951. IPD Sharing: YES. Countries: 13. Publications: 3.
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02621398. IPD Sharing: NO. Countries: 1. Publications: 1.
PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis
ClinicalTrials.gov study NCT04000906. IPD Sharing: YES. Countries: 1. Publications: 1.
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
ClinicalTrials.gov study NCT01522768. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.